{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:45:37Z","timestamp":1792100737453,"version":"4.4.0"},"reference-count":0,"publisher":"Portico","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2008.44.5.1186403","type":"journal-article","created":{"date-parts":[[2009,8,5]],"date-time":"2009-08-05T06:48:53Z","timestamp":1249454933000},"page":"353","source":"Crossref","is-referenced-by-count":43,"title":["Gabapentin: A Ca2+ channel alpha2-delta ligand far beyond epilepsy\ntherapy"],"prefix":"10.3730","volume":"44","author":[{"family":"Striano, P.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Striano, S.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1320","published-online":{"date-parts":[[2008]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:42:31Z","timestamp":1685454151000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7ddfsqj"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":0,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2008.44.5.1186403","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}